Detalles de la búsqueda
1.
Selinexor in combination with weekly paclitaxel in patients with metastatic solid tumors: Results of an open label, single-center, multi-arm phase 1b study with expansion phase in ovarian cancer.
Gynecol Oncol
; 168: 76-82, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36423446
2.
Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: Results of a single-center, multi-arm phase Ib study.
Invest New Drugs
; 40(2): 290-299, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34562230
3.
Effects of glutamine for prevention of radiation-induced esophagitis: a double-blind placebo-controlled trial.
Invest New Drugs
; 39(4): 1113-1122, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33580845
4.
Selinexor in combination with topotecan in patients with advanced or metastatic solid tumors: Results of an open-label, single-center, multi-arm phase Ib study.
Invest New Drugs
; 39(5): 1357-1365, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33909232
5.
Correction to: Selinexor in combination with topotecan in patients with advanced or metastatic solid tumors: Results of an open-label, single-center, multi-arm phase Ib study.
Invest New Drugs
; 40(2): 461, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-34705134
6.
Correction to: Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: results of a singlecenter, multiarm phase Ib study.
Invest New Drugs
; 40(2): 463, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-34731355
7.
Evaluation of a novel blood pressure scoring method and its association with clinical response in cancer patients treated with anti-vascular endothelial growth factor therapy.
Invest New Drugs
; 32(4): 717-22, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24764123
8.
Barriers to study enrollment in patients with advanced cancer referred to a phase I clinical trials unit.
Oncologist
; 18(12): 1315-20, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-24153239
9.
Preoperative factors predicting survival after secondary cytoreduction for recurrent ovarian cancer.
Int J Gynecol Cancer
; 21(5): 831-6, 2011 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-21613957
10.
Selinexor in combination with standard chemotherapy in patients with advanced or metastatic solid tumors.
Exp Hematol Oncol
; 10(1): 59, 2021 Dec 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-34965890
11.
Evaluating the psychometric properties of the Immunotherapy module of the MD Anderson Symptom Inventory.
J Immunother Cancer
; 8(2)2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33097611
12.
Phase 2 study of pembrolizumab in patients with advanced rare cancers.
J Immunother Cancer
; 8(1)2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32188704
13.
Incidence of mucositis in patients treated with temsirolimus-based regimens and correlation to treatment response.
Oncologist
; 19(4): 426-8, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24668327
14.
Prevalence of Complementary Medicine Use in Patients With Cancer: A Turkish Comprehensive Cancer Center Experience.
J Glob Oncol
; 4: 1-6, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30241173
15.
Selinexor in Combination with Carboplatin and Pemetrexed in Patients with Advanced or Metastatic Solid Tumors: Results of an Open-Label, Single-Center, Multi-Arm Phase 1b Study.
J Immunother Precis Oncol
; 5(1): 10-12, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35663832
16.
Phase I dose escalation study of temsirolimus in combination with metformin in patients with advanced/refractory cancers.
Cancer Chemother Pharmacol
; 77(5): 973-7, 2016 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-27014780
17.
Role of appendectomy at the time of primary surgery in patients with early-stage ovarian cancer.
Gynecol Oncol
; 103(3): 888-90, 2006 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-16806436
Resultados
1 -
17
de 17
1
Próxima >
>>